17th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals

BioAgilytix

Gold sponsor

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.

For more information, please visit the BioAgilytix website

Celerion

Gold sponsor

Celerion, an early clinical research organization, has the experience and capacity to exceed your bioanalytical expectations from method development and validation through rapid sample analysis supporting studies from late discovery through preclinical and late stage clinical development. With over 40 years’ experience, laboratories in Zürich, Switzerland and Lincoln, Nebraska USA, combining state-of-the-art technology and scientific expertise to accelerate the drug development by rapidly delivering high-quality data for comprehensive immunogenicity assessments, pharmacokinetics and biomarkers.

For more information, please visit the Celerion website

KCAS Bio

Gold sponsor

KCAS Bio is a leading bioanalytical contract research organization (CRO) with a proven record of advancing drug development worldwide. We have supported more than 315 FDA-approved drugs, developed over 6,200 proprietary and non-proprietary assays, and successfully completed more than 20 FDA audits with no major findings. As a top bioanalytical CRO lab, we continually invest in the latest instrumentation and combine this technical expertise with a consultative approach, ensuring our clients’ goals are achieved with confidence. Our teams also bring specialized expertise in advanced modalities, allowing us to support the evolving needs of modern drug development. By consistently benchmarking and optimizing our operations, we help scientific innovators and investors move forward with greater certainty. With facilities across the US and Europe, along with a strategic alliance in Australia, we provide global sponsors with comprehensive services including bioanalytical, biomarker, immunogenicity, cellular and molecular assay capabilities, as well as clinical kitting and sample management.

For more information, please visit the KCAS Bio website

QPS

Gold sponsor

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, and Asia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, cell therapy products (such as Leukopaks and PBMCs), clinical trials, and clinical research services. QPS has four advanced bioanalytical facilities in the US, Netherlands, Taiwan and India to serve the evolving needs of the Pharmaceutical and Biotech industries. Our staff are experts in the analysis of conventional matrices (plasma, serum, whole-blood, urine, feces), as well as various animal and human tissues

For more information, please visit the QPS website

Resolian

Gold sponsor

Resolian is a leading global Contract Research Organization (CRO) providing specialized services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetic (DMPK), and GMP CMC analytical and materials science. Its team of more than 500 experts across the US, UK, and Australia, Resolian supports pharma and biotech companies’ programs throughout the entire drug development continuum.

For more information, please visit the Resolian website

Svar Life Science

Gold sponsor

Svar Life Science is a Swedish group of companies that invents, develops, and applies the best assay technology for drug development and clinical diagnostics with the goal of delivering new solutions tailored to customer requirements. They offer advanced technology platforms such as Functional Complement Biomarker and Screening assays and Cell-based Reporter Gene assays, as well as unique service models for Bioassays Customization, Custom Cell line Development in combination with GxP Laboratory Services, all designed to meet their customers’ specific project needs.

For more information, please visit the Svar Life Science website

ACM Global Laboratories

Bronze sponsor

ACM Bioanalytical Services, can help optimize your drug development program and ensure that you have the technical insight needed to successfully complete your bioanalytical studies. Our chemists have the expertise and flexibility to assist you with complex assay method development and validation for the quantification of drugs, metabolites, and biomarkers in biological samples. Pharmaceutical research and development is a complex and demanding endeavor. While the pace and scope of scientific information accumulates rapidly, most clinical trials take approximately seven years to complete. However, on average less than 12% of drugs entering clinical testing are approved. To increase the likelihood of success, it is critical to connect with experts that understand the complexities of the industry.

For more information, please visit the ACM Global Laboratories website

ImmuneSpec

Bronze sponsor

ImmuneSpec is your partner for MAPPs.

We combine high-sensitivity immunopeptidomics with optimized workflows to uncover MHC-presented peptides and deliver the most complete immunogenic profile of your biotherapeutic by identifying all putative immunogenic T cell epitopes. ImmuneSpec enables rapid and reliable identification of immunogenic peptides, precisely mapping the peptide regions that trigger an immune response.

Our approach integrates:

• Optimized MHC peptide purification – ensuring efficient solubilization, purification, and extraction.
• Precision mass spectrometry (TimsTOF-ULTRA2) – enabling ultra-precise peptide detection.
• Extensive data analysis pipelines – maximizing the identification of true immunopeptides.

This makes ImmuneSpec the trusted partner for biotech, pharma, and clinicians seeking MAPPs- and immunopeptidomics-based insights into the T cell epitopes that drive immune responses. We deliver powerful data for (unwanted) immunogenicity risk assessment, immunotherapy development, precision medicine, and vaccine research.

For more information, please visit the ImmuneSpec website

Institute Krems Bioanalytics

Bronze sponsor

Krems Bioanalytics is a contract research institute providing cutting-edge bioanalytical services in the fields of immunology, hematology, and oncology since 2014. We have a long-standing expertise in the development and validation of customised and GxP compliant analytical assays for large molecules and vaccines. We offer sample analytics for early and late preclinical studies (R&D or GLP) and for clinical trials (GCP).

For more information, please visit the Institute Krems Bioanalytics website